Global Biosimilars Market Insights, Forecast to 2025

Table of Contents

1 Biosimilars Market Overview

• 1.1 Product Overview and Scope of Biosimilars
• 1.2 Biosimilars Segment by Type
  • 1.2.1 Global Biosimilars Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
  • 1.2.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
  • 1.2.4 Peptides (Glucagon, Calcitonin)
• 1.3 Biosimilars Segment by Application
  • 1.3.1 Biosimilars Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Oncology
  • 1.3.3 Blood Disorders
• 1.4 Global Biosimilars Market Size Estimates and Forecasts
  • 1.4.1 Global Biosimilars Revenue 2015-2026
  • 1.4.2 Global Biosimilars Sales 2015-2026
  • 1.4.3 Biosimilars Market Size by Region: 2020 Versus 2026

2 Global Biosimilars Market Competition by Manufacturers

• 2.1 Global Biosimilars Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Biosimilars Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Biosimilars Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Biosimilars Manufacturing Sites, Area Served, Product Type
• 2.5 Biosimilars Market Competitive Situation and Trends
  • 2.5.1 Biosimilars Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Biosimilars Players (Opinion Leaders)

3 Biosimilars Retrospective Market Scenario by Region

• 3.1 Global Biosimilars Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Biosimilars Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Biosimilars Market Facts & Figures by Country
  • 3.3.1 North America Biosimilars Sales by Country
  • 3.3.2 North America Biosimilars Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Biosimilars Market Facts & Figures by Country
  • 3.4.1 Europe Biosimilars Sales by Country
  • 3.4.2 Europe Biosimilars Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Biosimilars Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Biosimilars Sales by Region
  • 3.5.2 Asia Pacific Biosimilars Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Biosimilars Market Facts & Figures by Country
  • 3.6.1 Latin America Biosimilars Sales by Country
  • 3.6.2 Latin America Biosimilars Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Biosimilars Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Biosimilars Sales by Country
  • 3.7.2 Middle East and Africa Biosimilars Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Biosimilars Historic Market Analysis by Type

• 4.1 Global Biosimilars Sales Market Share by Type (2015-2020)
• 4.2 Global Biosimilars Revenue Market Share by Type (2015-2020)
• 4.3 Global Biosimilars Price Market Share by Type (2015-2020)
• 4.4 Global Biosimilars Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Biosimilars Historic Market Analysis by Application

• 5.1 Global Biosimilars Sales Market Share by Application (2015-2020)
• 5.2 Global Biosimilars Revenue Market Share by Application (2015-2020)
• 5.3 Global Biosimilars Price by Application (2015-2020)

6 Company Profiles and Key Figures in Biosimilars Business

• 6.1 Pfizer
  • 6.1.1 Corporation Information
  • 6.1.2 Pfizer Description, Business Overview and Total Revenue
  • 6.1.3 Pfizer Biosimilars Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Pfizer Products Offered
  • 6.1.5 Pfizer Recent Development
• 6.2 Sandoz International GmbH
  • 6.2.1 Sandoz International GmbH Biosimilars Production Sites and Area Served
  • 6.2.2 Sandoz International GmbH Description, Business Overview and Total Revenue
  • 6.2.3 Sandoz International GmbH Biosimilars Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Sandoz International GmbH Products Offered
  • 6.2.5 Sandoz International GmbH Recent Development
• 6.3 Teva Pharmaceuticals Industries
  • 6.3.1 Teva Pharmaceuticals Industries Biosimilars Production Sites and Area Served
  • 6.3.2 Teva Pharmaceuticals Industries Description, Business Overview and Total Revenue
  • 6.3.3 Teva Pharmaceuticals Industries Biosimilars Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Teva Pharmaceuticals Industries Products Offered
  • 6.3.5 Teva Pharmaceuticals Industries Recent Development
• 6.4 Amgen Inc
  • 6.4.1 Amgen Inc Biosimilars Production Sites and Area Served
  • 6.4.2 Amgen Inc Description, Business Overview and Total Revenue
  • 6.4.3 Amgen Inc Biosimilars Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Amgen Inc Products Offered
  • 6.4.5 Amgen Inc Recent Development
• 6.5 Biocon
  • 6.5.1 Biocon Biosimilars Production Sites and Area Served
  • 6.5.2 Biocon Description, Business Overview and Total Revenue
  • 6.5.3 Biocon Biosimilars Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Biocon Products Offered
  • 6.5.5 Biocon Recent Development
• 6.6 Dr. Reddy’s Laboratories
  • 6.6.1 Dr. Reddy’s Laboratories Biosimilars Production Sites and Area Served
  • 6.6.2 Dr. Reddy’s Laboratories Description, Business Overview and Total Revenue
  • 6.6.3 Dr. Reddy’s Laboratories Biosimilars Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Dr. Reddy’s Laboratories Products Offered
  • 6.6.5 Dr. Reddy’s Laboratories Recent Development
• 6.7 F. Hoffmann-La Roche
  • 6.6.1 F. Hoffmann-La Roche Biosimilars Production Sites and Area Served
  • 6.6.2 F. Hoffmann-La Roche Description, Business Overview and Total Revenue
  • 6.6.3 F. Hoffmann-La Roche Biosimilars Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 F. Hoffmann-La Roche Products Offered
  • 6.7.5 F. Hoffmann-La Roche Recent Development
• 6.8 Celltrion
  • 6.8.1 Celltrion Biosimilars Production Sites and Area Served
  • 6.8.2 Celltrion Description, Business Overview and Total Revenue
  • 6.8.3 Celltrion Biosimilars Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Celltrion Products Offered
  • 6.8.5 Celltrion Recent Development
• 6.9 Samsung Bioepis
  • 6.9.1 Samsung Bioepis Biosimilars Production Sites and Area Served
  • 6.9.2 Samsung Bioepis Description, Business Overview and Total Revenue
  • 6.9.3 Samsung Bioepis Biosimilars Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Samsung Bioepis Products Offered
  • 6.9.5 Samsung Bioepis Recent Development

7 Biosimilars Manufacturing Cost Analysis

• 7.1 Biosimilars Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Biosimilars
• 7.4 Biosimilars Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Biosimilars Distributors List
• 8.3 Biosimilars Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Biosimilars Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Biosimilars by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Biosimilars by Type (2021-2026)
• 10.2 Biosimilars Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Biosimilars by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Biosimilars by Application (2021-2026)
• 10.3 Biosimilars Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Biosimilars by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Biosimilars by Region (2021-2026)
• 10.4 North America Biosimilars Estimates and Projections (2021-2026)
• 10.5 Europe Biosimilars Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Biosimilars Estimates and Projections (2021-2026)
• 10.7 Latin America Biosimilars Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Biosimilars Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List